{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=PMA&page=9", "query": { "condition": "PMA", "page": 9 }, "page_size": 10 }, "pagination": { "page": 9, "page_size": 10, "total_count": 223, "total_pages": 23, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=PMA&page=10&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=PMA&page=8&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-22T09:40:53.206Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03254199", "title": "A Study to Assess the Safety and Effectiveness of FLX-787 in Subjects With Charcot-Marie-Tooth Disease Experiencing Muscle Cramps.", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Charcot-Marie-Tooth Disease" ], "interventions": [ { "name": "FLX-787-ODT (orally disintegrating tablet)", "type": "DRUG" }, { "name": "Placebo ODT", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Flex Pharma, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 27, "start_date": "2017-10-16", "completion_date": "2018-07-27", "has_results": false, "last_update_posted_date": "2018-08-29", "last_synced_at": "2026-10-22T09:40:53.206Z", "location_count": 20, "location_summary": "Scottsdale, Arizona • Aurora, Colorado • New Britain, Connecticut + 16 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Aurora", "state": "Colorado" }, { "city": "New Britain", "state": "Connecticut" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03254199" }, { "nct_id": "NCT06919289", "title": "The Investigators Are Comparing Lidocaine and Papaverine Nerve Blocks to Determine Which Improves Blood Flow Better, Making the \"Phoenix Sign\" Clearer on Imaging. This Helps Accurately Diagnose Nerve Compression, Improving Patient Care", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Drop Foot" ], "interventions": [ { "name": "Infiltration of papaverine", "type": "DRUG" }, { "name": "Lidocaine infiltration", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "US Neuropathy Centers", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 4, "start_date": "2024-03-07", "completion_date": "2024-07-01", "has_results": false, "last_update_posted_date": "2025-04-09", "last_synced_at": "2026-10-22T09:40:53.206Z", "location_count": 1, "location_summary": "Jasper, Indiana", "locations": [ { "city": "Jasper", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT06919289" }, { "nct_id": "NCT04662320", "title": "Promoting Healing of Nerves Through Electrical Stimulation", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cubital Tunnel Syndrome", "Nerve Compression", "Nerve Injury", "Ulnar Neuropathies" ], "interventions": [ { "name": "Checkpoint BEST System", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Checkpoint Surgical Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 100, "start_date": "2021-09-01", "completion_date": "2025-12", "has_results": false, "last_update_posted_date": "2024-12-05", "last_synced_at": "2026-10-22T09:40:53.206Z", "location_count": 5, "location_summary": "Stanford, California • Chicago, Illinois • St Louis, Missouri + 2 more", "locations": [ { "city": "Stanford", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Milwaukee", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT04662320" }, { "nct_id": "NCT06092346", "title": "A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "AMPD3, OMIM*102772, AMP Deaminase Deficiency", "AK1, OMIM *103000, Adenylate Kinase Deficiency", "AMPD1, OMIM *102770, Myopathy Due to Myoadenylate Deaminase Deficiency", "TPMT, OMIM *187680, Thoipurines, Poor Metabolism of", "IMPDH1, OMIM *146690, Retinitis Pigmentosa Type 10, Leber Congenital Amauriosis Type 11", "APRT, OMIM *102600, Adenine Phosphoribosyltransferase Deficiency", "HPRT1, OMIM *308000 Lesch-Nyhan Disease", "XDH, OMIM *607633, Xanthinuria Type 1", "SLC2A9, OMIM *606142 Hypouricemia", "SLC22A12, OMIM *607096 Hypouricemia", "PRPS1 Def, OMIM *311850, Arts Syndrome; Charcot-Marie-Tooth Disease", "PRPS1 SA, OMIM *311850 Gout, PRPS-related Phosphoribosylpyrophosphate Synthetase Superactivity", "AMPD2, OMIM *102771, Spastic Paraplegia 63; Pontocerebellar Hypoplasia", "ITPA, OMIM *147520, Inosine Triphosphatase Deficiency; Developmental and Epileptic Encephalopathy 35", "ADSL, OMIM *608222, Adenylosuccinate Lyase Deficiency", "PNP, OMIM *164050, Nucleoside Phosphorylase Deficiency", "ADA2, OMIM *607575,Sneddon Syndrome; VAIHS", "CAD, *1140120, Developmental and Epileptic Encephalopathy", "UPB1, OMIM *606673, Beta-ureidopropionase Deficiency", "DPYS, OMIM *613326, Dihydropyrimidinase Deficiency", "DPYD, OMIM *274270, Dihydropyrimidine Dehydrogenase Deficiency", "DHODH, OMIM *126064, Miller Syndrome (Postaxial Acrofacial Dysostosis)", "UMPS, OMIM *613891, Orotic Aciduria", "NT5C3A, OMIM *606224, Anemia, Hemolytic, Due to UMPH1 Deficiency", "UNG, OMIM *191525, Hyper-IgM Syndrome 5", "AICDA, OMIM *605257, Immunodeficiency With Hyper-IgM, Type 2; HIGM2", "Purine-Pyrimidine Metabolism", "Metabolic Disease" ], "interventions": [], "intervention_types": [], "sponsor": "National Human Genome Research Institute (NHGRI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Month", "maximum_age": "100 Years", "sex": "ALL", "summary": "1 Month to 100 Years" }, "enrollment_count": 999, "start_date": "2023-12-19", "completion_date": "2099-01-01", "has_results": false, "last_update_posted_date": "2026-08-19", "last_synced_at": "2026-10-22T09:40:53.206Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT06092346" }, { "nct_id": "NCT05332405", "title": "SPY Angiography To Assist With Ulnar Nerve Transposition at the Elbow", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Cubital Tunnel Syndrome" ], "interventions": [ { "name": "Indocyanine green", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 0, "start_date": "2022-05-26", "completion_date": "2024-04-01", "has_results": false, "last_update_posted_date": "2023-06-29", "last_synced_at": "2026-10-22T09:40:53.206Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05332405" }, { "nct_id": "NCT07447557", "title": "Study of Intrathecal ELP-02 for Charcot-Marie-Tooth Disease Type 4J (CMT4J)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Charcot-Marie-Tooth Disease Type 4J" ], "interventions": [ { "name": "ELP-02", "type": "GENETIC" } ], "intervention_types": [ "GENETIC" ], "sponsor": "Elpida Therapeutics SPC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "20 Years", "sex": "ALL", "summary": "3 Years to 20 Years" }, "enrollment_count": 8, "start_date": "2026-08-07", "completion_date": "2032-12", "has_results": false, "last_update_posted_date": "2026-09-09", "last_synced_at": "2026-10-22T09:40:53.206Z", "location_count": 2, "location_summary": "Palo Alto, California • Iowa City, Iowa", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT07447557" }, { "nct_id": "NCT07223632", "title": "Treatment of Charcot-Marie-Tooth Disease, Axonal, Type 2S (CMT2S) in an Individual Patient", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Charcot Marie Tooth Disease (CMT)", "Neuromuscular Diseases (NMD)" ], "interventions": [ { "name": "VCA-894A", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vanda Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "FEMALE", "summary": "Female only" }, "enrollment_count": 1, "start_date": "2025-05-13", "completion_date": "2027-03", "has_results": false, "last_update_posted_date": "2026-08-19", "last_synced_at": "2026-10-22T09:40:53.206Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT07223632" }, { "nct_id": "NCT06188221", "title": "Does Adding Lidocaine to Corticosteroid Injections Reduce Pain Intensity in Hand Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hand Osteoarthritis", "Trigger Finger", "Carpal Tunnel Syndrome" ], "interventions": [ { "name": "Lidocaine", "type": "DRUG" }, { "name": "Corticoids", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Texas at Austin", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "89 Years", "sex": "ALL", "summary": "18 Years to 89 Years" }, "enrollment_count": 40, "start_date": "2020-02-01", "completion_date": "2023-07-01", "has_results": false, "last_update_posted_date": "2024-01-03", "last_synced_at": "2026-10-22T09:40:53.206Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06188221" }, { "nct_id": "NCT04811287", "title": "PRP as Adjuvant Treatment to CTR for Severe CTS Tunnel Syndrome", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Carpal Tunnel Syndrome", "PRP" ], "interventions": [ { "name": "Carpal Tunnel Release with Platelet-Rich Plasma", "type": "DEVICE" }, { "name": "Carpal Tunnel Release without Platelet-Rich Plasma", "type": "PROCEDURE" } ], "intervention_types": [ "DEVICE", "PROCEDURE" ], "sponsor": "Michael Fredericson, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 15, "start_date": "2021-10-15", "completion_date": "2025-07-01", "has_results": true, "last_update_posted_date": "2026-04-30", "last_synced_at": "2026-10-22T09:40:53.206Z", "location_count": 1, "location_summary": "Redwood City, California", "locations": [ { "city": "Redwood City", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04811287" }, { "nct_id": "NCT06425575", "title": "Resolution of Pudendal Neuralgia in Chronic Pelvic Pain Using a Novel Biologic Therapy", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Chronic Pelvic Pain Syndrome" ], "interventions": [ { "name": "Amniotic suspension allograft", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Thomas Jefferson University", "sponsor_class": "OTHER", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 50, "start_date": "2019-04-01", "completion_date": "2024-07-01", "has_results": false, "last_update_posted_date": "2024-05-22", "last_synced_at": "2026-10-22T09:40:53.206Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06425575" } ] }